Close Menu

A University of Pennsylvania-led team reports the Proceedings of the National Academy of Sciences this week that it developed a potential gene therapy for retinitis pigmentosa. The condition has been linked to more than a hundred different mutations in the rhodopsin gene, RHO. The research team combined an shRNA that targets RHO, independent of mutations in it, with a RHO replacement cDNA that is resistant to RNA interference on a single adeno-associated viral vector.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.